Literature DB >> 7563172

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.

R M Elledge1, R Gray, E Mansour, Y Yu, G M Clark, P Ravdin, C K Osborne, K Gilchrist, N E Davidson, N Robert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7563172     DOI： 10.1093/jnci/87.16.1254

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  15 in total

1.  Treating breast cancer before surgery.

Authors:  R Epstein
Journal:  BMJ       Date:  1996-11-30

2.  Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.

Authors:  C Kent Osborne; Patrick Neven; Luc Y Dirix; John R Mackey; Jean Robert; Craig Underhill; Rachel Schiff; Carolina Gutierrez; Ilenia Migliaccio; Valsamo K Anagnostou; David L Rimm; Patrick Magill; Mark Sellers
Journal:  Clin Cancer Res       Date:  2011-01-10       Impact factor: 12.531

3.  Apoptosis of haematopoietic cells upon thymidylate synthase inhibition is independent of p53 accumulation and CD95-CD95 ligand interaction.

Authors:  C Muñoz-Pinedo; F J Oliver; A López-Rivas
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

4.  Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.

Authors:  A M Thompson; D N Crichton; R A Elton; M F Clay; U Chetty; C M Steel
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

Review 5.  Clinical implication of p53 mutation in lung cancer.

Authors:  Barbara G Campling; Wafik S El-Deiry
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

6.  Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Authors:  E Niskanen; C Blomqvist; K Franssila; P Hietanen; V M Wasenius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53.

Authors:  S Rauth; J Kichina; A Green
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.

Authors:  T Brodowicz; C Wiltschke; D Kandioler-Eckersberger; T W Grunt; M Rudas; S M Schneider; M Hejna; A Budinsky; C C Zielinski
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

9.  Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.

Authors:  Y Maehara; M Tomoda; S Hasuda; A Kabashima; E Tokunaga; Y Kakeji; K Sugimachi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.

Authors:  T Brodowicz; D Kandioler; S Tomek; C Ludwig; M Rudas; R Kunstfeld; W Koestler; M Hejna; A Budinsky; C Wiltschke; C C Zielinski
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.